Breast Cancer: 1,219 Real Stories

1,219 stories match breast cancer. 974 of them mention surgery.

Amy, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Amy's Patient Story

Patient Info: Amy Dowden, Female, Under 40

As of March 2024, Amy Dowden had publicly shared her breast cancer diagnosis at 32 and was discussing diagnosis, treatment in public life, and dance.

So Now I've Got Breast Cancer
OutcomeCare Ongoing
Leslie, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Stage IV Invasive Lobular Carcinoma: Leslie's Patient Story

Patient Info: Leslie, Female, 50s | Stage IV

Metastatic Site: Bone: spine, ribs, pelvis

Leslie was diagnosed at 56 with de novo metastatic ILC after an initial Stage II biopsy result was revised to Stage IV when MRI showed numerous bone metastases, and her cancer was well controlled on targeted drugs as of February 2024.

Lobular Breast Cancer Alliance
OutcomeLiving With Cancer
Loriana, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Loriana's Survivor Story

Patient Info: Loriana, Female

Biomarkers: Breast cancer biomarkers not reported

As of February 2024, Loriana was surviving after AML and later breast cancer, while living with chronic pain, depression, PTSD, and a strong advocacy role focused on patient support and self-advocacy.

The Patient Story
OutcomeSurvivorship / Completed Treatment
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

Rare soft-tissue sarcoma of the breast

Patient Info: Anonymized, Female | Stage IV

Biomarkers: TLE1 strongly and diffusely positive; p63, CK7

Metastatic Site: lungs

After mastectomy, the cancer was metastatic to the lungs and care was palliative.

PubMed Central
OutcomeLiving With Cancer
TB
Breast Cancer

Triple-Negative Breast Cancer: Katrina's Survivor Story

Patient Info: Katrina M. Johnson, Female

Biomarkers: ER-negative; PR-negative; HER2-negative

As of February 2024, Katrina M. Johnson was a triple-negative breast cancer survivor, three-time breast cancer survivor, and two-time melanoma survivor discussing self-care after diagnosis.

Dear Cancer, I'm Beautiful (LBBC)
OutcomeSurvivorship / Completed Treatment
Debbie, who was diagnosed with Stage I Breast AdenocarcinomaBreast Cancer

Stage I Breast Adenocarcinoma: Debbie's Survivor Story

Patient Info: Debbie Wade, Female | Stage I

As of February 2024, Debbie was cancer-free after double mastectomy, 4 weeks of radiation therapy and DIEP flap reconstruction for Stage I mucinous adenocarcinoma of the left breast, with mild left-arm lymphedema as the only reported side effect.

MD Anderson
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

Metastatic hormone receptor-positive breast cancer with paraneoplastic eosinophilic fasciitis

Patient Info: Anonymized, Female, 70+ | Stage IV

Biomarkers: ER-positive; PR-positive; eosinophilia during paraneoplastic eosinophilic fasciitis flare

Metastatic Site: pelvis

As of February 2024, paraneoplastic eosinophilic fasciitis had remitted after prednisone plus systemic breast-cancer therapy, and 6-month follow-up showed no further skin recurrence or cancer progression.

PubMed Central
OutcomeResponding Well
Dena, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV BRCA Breast Cancer: Dena's Patient Story

Patient Info: Dena Ofengeim, Under 40 | Stage IV

Biomarkers: Hormone receptor-positive; BRCA mutation

Metastatic Site: spine

Dena improved rapidly after treatment, regained her mobility, returned to an active life, and remained on therapy for metastatic breast cancer.

Dana-Farber
OutcomeResponding Well
A patient, who was diagnosed with Invasive Lobular CarcinomaBreast Cancer

Male Invasive Lobular Breast Cancer With a Pathogenic PALB2 Variant

Patient Info: Anonymized, male, 40s

Biomarkers: ER-positive; PR-positive; HER2 not amplified; pathogenic PALB2 variant

He was disease-free at 1-year follow-up after mastectomy, chemotherapy, and radiotherapy.

PubMed Central
OutcomeCancer-Free / NED
Sally, who was diagnosed with Invasive Ductal CarcinomaBreast Cancer

Invasive Ductal Carcinoma: Sally's Patient Story

Patient Info: Sally Johnston, 70+

Her follow-up for the earlier ductal carcinoma in situ had ended before she returned to Dana-Farber about 20 years later with a separate lobular breast cancer.

Dana-Farber
OutcomeNot reported
Sally, who was diagnosed with Invasive Lobular CarcinomaBreast Cancer

Invasive Lobular Carcinoma: Sally's Survivor Story

Patient Info: Sally Johnston, 70+

Biomarkers: Estrogen receptor-positive

Sally was in remission by the end of 2014 and remained active about 10 years after treatment.

Dana-Farber
OutcomeCancer-Free / NED
A patient, who was diagnosed with Breast CancerBreast Cancer

Aggressive breast cancer presenting with severe skin infection

Patient Info: Anonymized, Female

Biomarkers: ER 99% positive; PR 99% positive; HER2 1+ / negative; Ki-67 3%; grade 2; 3 interpectoral lymph nodes negative; later axillary-node biopsy benign

She recovered from sepsis and surgery, had no distant metastases and a benign axillary-node biopsy, and was receiving adjuvant radiation with anastrozole ongoing.

PubMed Central
OutcomeCare Ongoing
Paula, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Paula's Patient Story

Patient Info: Paula | Stage II

Paula was receiving chemotherapy and hormonal therapy for stage 2 breast cancer, with additional treatments included in the recommended plan.

Our Cancer Stories
OutcomeCare Ongoing
A patient, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Metastatic invasive lobular breast carcinoma to pancreas: biliary stent and paclitaxel

Patient Info: Anonymized, Female, 40s | Stage IV

Biomarkers: Primary breast tumor was triple-negative. Pancreatic metastasis was ER-positive/GATA-positive

Metastatic Site: pancreas; coelio-mesenteric lymph nodes

After 21 years of remission, she developed pancreatic and coelio-mesenteric nodal metastases from invasive lobular breast carcinoma; palliative paclitaxel was stopped after 2 courses because her condition deteriorated, and she was lost to follow-up.

PubMed Central
OutcomeSetback / Progression